1. Home
  2. CF vs UTHR Comparison

CF vs UTHR Comparison

Compare CF & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CF Industries Holdings Inc.

CF

CF Industries Holdings Inc.

HOLD

Current Price

$78.05

Market Cap

14.0B

Sector

Industrials

ML Signal

HOLD

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$488.92

Market Cap

20.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CF
UTHR
Founded
1946
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.0B
20.3B
IPO Year
2005
1999

Fundamental Metrics

Financial Performance
Metric
CF
UTHR
Price
$78.05
$488.92
Analyst Decision
Hold
Buy
Analyst Count
15
12
Target Price
$92.50
$495.08
AVG Volume (30 Days)
2.4M
424.3K
Earning Date
11-05-2025
10-29-2025
Dividend Yield
2.57%
N/A
EPS Growth
31.44
16.08
EPS
8.27
26.38
Revenue
$6,736,000,000.00
$3,128,400,000.00
Revenue This Year
$21.13
$13.64
Revenue Next Year
N/A
$5.78
P/E Ratio
$9.42
$18.55
Revenue Growth
12.59
13.50
52 Week Low
$67.34
$266.98
52 Week High
$104.45
$492.62

Technical Indicators

Market Signals
Indicator
CF
UTHR
Relative Strength Index (RSI) 38.45 68.10
Support Level $78.08 $470.13
Resistance Level $80.94 $492.62
Average True Range (ATR) 1.96 10.72
MACD 0.12 -0.53
Stochastic Oscillator 16.70 89.55

Price Performance

Historical Comparison
CF
UTHR

About CF CF Industries Holdings Inc.

CF Industries is a leading producer and distributor of nitrogen, which is primarily used in fertilizers. The company operates nitrogen manufacturing plants primarily in North America. CF also produces nitrogen in the United Kingdom and holds a joint venture interest in a nitrogen production facility in Trinidad and Tobago. CF makes nitrogen primarily using low-cost US natural gas as its feedstock, making the company one of the lowest-cost nitrogen producers globally. It is also investing in carbon-free blue and green ammonia, which can be used as an alternative fuel to hydrogen or as a means to transport hydrogen.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Share on Social Networks: